GlassScriptPhysician profile
Han Soo Bae
NPI 1316998792
$6,669.36
in general payments reported to CMS, 2019-2025
27 companies · $1,930 in 2025
The $1,930 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $360 · 2021: $859 · 2022: $815 · 2023: $967 · 2024: $919 · 2025: $1,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,558 · Education: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,557.50 |
| Education | $258.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,219.72 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $771.60 | 2020-2025 | Dupixent |
| Optinose US, INC. | $749.83 | 2019-2025 | |
| Genzyme Corporation | $705.80 | 2021-2025 | |
| Harmony Biosciences LLC | $613.24 | 2023-2025 | Wakix |
| Inspire Medical Systems, INC. | $581.22 | 2021-2025 | Inspire |
| Intersect Ent, INC. | $410.41 | 2019-2020 | |
| Glaxosmithkline, LLC. | $301.96 | 2022-2025 | Nucala |
| Alk-Abello, INC | $242.20 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Avadel Cns Pharmaceuticals, LLC | $228.41 | 2024-2025 | Lumryz |
| Aerin Medical INC. | $168.64 | 2019-2025 | |
| Axsome Therapeutics, INC. | $153.25 | 2024-2025 | Sunosi |
| Cook Medical LLC | $93.02 | 2019 | |
| Stryker Corporation | $90.63 | 2019-2022 | |
| Phadia US INC. | $43.84 | 2021-2023 | Immunocap |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortovia Therapeutics, INC. | $41.13 | 2019 | |
| Hologic Sales and Service, LLC | $40.95 | 2023 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $33.88 | 2021-2023 | Belsomra |
| Arbor Pharmaceuticals, INC. | $31.73 | 2021 | |
| Acclarent, INC | $27.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.90 | 2021 | |
| Boston Scientific Corporation | $21.67 | 2023 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $19.30 | 2021 | |
| Philips North America LLC | $17.15 | 2019 | |
| Medtronic, INC. | $16.42 | 2023 | Pteye Parathyroid Detection System |
| Xoran Technologies LLC | $11.25 | 2023 | Minicat |
| Greer Laboratories, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han Soo Bae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.